Merck & Co. Inc. (MRK): One of the Best Low Risk High Growth Stocks to Buy Right Now

We just covered the 14 Best Low Risk High Growth Stocks to Buy Right Now and Merck & Co., Inc. (NYSE:MRK) ranks 6th on this list.

It is no secret that the pharmaceutical industry is facing a super-cliff of patent expirations, Merck & Co., Inc. (NYSE:MRK) has successfully de-risked its future by diversifying its oncology portfolio and scaling its multi-billion dollar cardiovascular and vaccine franchises. Elite investors are treating the stock as a growth play due to the launch of Winrevair. Recently released data from the CADENCE trial provided definitive proof-of-concept for Winrevair in treating heart failure with preserved ejection fraction. Analysts predict this drug could capture 2-3 times its original market target, turning it into a $5 billion+ annual revenue powerhouse by 2028. This success is vital because it provides high-margin growth that is entirely independent of Merck’s flagship drug, Keytruda.

Citigroup Inc. (C): Among Incredibly Cheap Dividend Stock to Buy Now

Merck & Co., Inc. (NYSE:MRK) continues to report double-digit international growth for its HPV vaccine, Gardasil. New long-term efficacy data presented at the EUROGIN 2026 Congress reinforced its status as a non-optional global health utility. Earlier this month, the European Commission approved ENFLONSIA for RSV prevention in infants, positioning Merck to capture a significant share of the multi-billion dollar RSV immunization market. The firm maintains a massive cash flow and a low Beta of 0.26. It is a favorite for income-focused funds, currently trading with a forward P/E of roughly 20x.

While we acknowledge the risk and potential of MRK as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than MRK and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXTIsrael Englander Stock Portfolio: Top 10 Stock Picks and Billionaire Stan Druckenmiller’s 10 Small and Mid-Cap Stock Picks with Huge Upside Potential.

Disclosure: None. Follow Insider Monkey on Google News.